STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
166
13F, latest reported quarter
What the filings say about SLAB
Insiders, 180 days
-$3.2M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-05-06
Planned sales (Form 144), 90 days
$1.4M
1 notice
Silicon Laboratories insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, SILICON LABORATORIES INC. insiders sold a net $3.2M of stock across 42 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on May 16, 2025.
The trade is 10.0% of the 80,519 shares held after it.
No other insider sold within 30 days.
166 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Johnson Robert Matthew sold about $1.7M of SLAB on May 18, 2026, the largest insider sale at the company since 2021; 166 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
SLAB planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
CONRAD ROBERT J
Filed 2026-08-14
$1.4M
SLAB mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
PAPP SMALL & MID-CAP GROWTH FUND
$1.4M position · as of 2026-05-31
3.5%
Dunham Monthly Distribution Fund
$10.0M position · as of 2026-07-31
3.2%
THE ARBITRAGE FUND
$22.7M position · as of 2026-05-31
2.7%
ProShares Merger ETF
$388.6K position · as of 2026-05-31
2.4%
AltShares Merger Arbitrage ETF
$2.4M position · as of 2026-05-31
2.3%
Global X Internet of Things ETF
$5.6M position · as of 2026-05-31
2.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · G. Tyson Tuttle
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$11.3M
$10.4M
$5.2M
+4%
+179%
2024
$7.2M
$5.6M
$2.8M
+0%
+92%
2023
$6.9M
-$8.8M
$2.3M
+4%
+55%
2022
$6.8M
$647.3K
$2.4M
+7%
-7%
2021
$17.0M
$21.0M
$4.4M
+62%
+43%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $3.2M sold by insiders over 180 days, 166 funds added last quarter, $1.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$855.9M
four quarters, 2025-07-06 to 2026-07-04
Revenue, TTM SLAB
FY Jan 2026
$784.8M
FY Dec 2024
$584.4M
FY Dec 2023
$782.3M
FY Dec 2022
$1.0B
FY Jan 2022
n/a
Jul 2026
$228.2M
Apr 2026
$213.5M
Jan 2026
$208.2M
Oct 2025
$206.0M
Jul 2025
$192.8M
Apr 2025
$177.7M
Dec 2024
$166.2M
Sep 2024
$166.4M
At each fiscal year end
Single quarter
Net margin, TTM
-4.6%
net income over revenue, 2025-07-06 to 2026-07-04
Net margin, TTM SLAB
FY Jan 2026
-8.3%
FY Dec 2024
n/a
FY Dec 2023
-4.4%
FY Dec 2022
+8.9%
FY Jan 2022
n/a
Jul 2026
-4.6%
Apr 2026
-7.4%
Jan 2026
-1.3%
Oct 2025
-4.8%
Jul 2025
-11.3%
Apr 2025
-17.1%
Dec 2024
-14.3%
Sep 2024
-17.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$5.4M
operating cash flow minus capex, 2025-07-06 to 2026-07-04
Free cash flow, TTM SLAB
FY Jan 2026
$65.8M
FY Dec 2024
-$25.7M
FY Dec 2023
-$52.6M
FY Dec 2022
$64.0M
FY Jan 2022
$61.9M
Jul 2026
-$26.8M
Apr 2026
-$4.9M
Jan 2026
-$1.6M
Oct 2025
$27.9M
Jul 2025
-$3.8M
Apr 2025
$43.3M
Dec 2024
$6.2M
Sep 2024
$29.4M
At each fiscal year end
Single quarter
Debt to equity
0.48x
long-term debt only, 2022-12-31 (42 months older than the period end); equity 2026-07-04
Debt to equity SLAB
FY Jan 2026
0.48x
FY Dec 2024
0.49x
FY Dec 2023
0.44x
FY Dec 2022
0.38x
FY Jan 2022
0.20x
Jul 2026
0.48x
Apr 2026
0.48x
Jan 2026
0.48x
Oct 2025
0.49x
Jul 2025
0.50x
Apr 2025
0.50x
Dec 2024
0.49x
Sep 2024
0.49x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.06x
TTM operating cash flow over long-term debt only, 2022-12-31 (42 months older than the period end)
Cash flow to debt SLAB
FY Jan 2026
0.18x
FY Dec 2024
-0.03x
FY Dec 2023
-0.06x
FY Dec 2022
0.17x
FY Jan 2022
0.20x
Jul 2026
0.06x
Apr 2026
0.10x
Jan 2026
0.18x
Oct 2025
0.18x
Jul 2025
0.18x
Apr 2025
0.20x
Dec 2024
-0.03x
Sep 2024
-0.01x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-3.6%
TTM net income over average of 2025-07-05 and 2026-07-04
Return on equity SLAB
FY Jan 2026
-6.0%
FY Dec 2024
n/a
FY Dec 2023
-2.6%
FY Dec 2022
+5.1%
FY Jan 2022
+124.1%
Jul 2026
-3.6%
Apr 2026
-4.6%
Jan 2026
-6.0%
Oct 2025
-8.0%
Jul 2025
-9.7%
Apr 2025
-14.8%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-3.2%
TTM net income over average of 2025-07-05 and 2026-07-04
Return on assets SLAB
FY Jan 2026
-5.2%
FY Dec 2024
n/a
FY Dec 2023
-1.9%
FY Dec 2022
+3.6%
FY Jan 2022
+85.5%
Jul 2026
-3.2%
Apr 2026
-4.0%
Jan 2026
-5.2%
Oct 2025
-6.9%
Jul 2025
-8.5%
Apr 2025
-12.8%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital SLAB
FY Jan 2026
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
+5.4%
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-3.9%
operating income (EBIT proxy) over average of 2025-07-05 and 2026-07-04 minus current liabilities
Return on capital employed SLAB
FY Jan 2026
-6.3%
FY Dec 2024
-13.8%
FY Dec 2023
-1.5%
FY Dec 2022
+5.6%
FY Jan 2022
-1.6%
Jul 2026
-3.9%
Apr 2026
-5.0%
Jan 2026
-6.3%
Oct 2025
-8.6%
Jul 2025
-10.1%
Apr 2025
-11.8%
Dec 2024
-13.8%
Sep 2024
-17.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing SLAB
FY Jan 2026
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
53.62x
FY Jan 2022
4.25x
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$7.5B
market value at close 2026-10-26 on 2026-08-04 shares, plus long-term debt only, 2022-12-31 (42 months older than the period end), minus cash 2026-07-04
Enterprise value SLAB
FY Jan 2026
$4.5B
FY Dec 2024
$4.4B
FY Dec 2023
$4.5B
FY Dec 2022
$4.5B
FY Jan 2022
$7.7B
Jul 2026
$7.4B
Apr 2026
$7.0B
Jan 2026
$4.5B
Oct 2025
$4.6B
Jul 2025
$5.2B
Apr 2025
$3.2B
Dec 2024
$4.4B
Sep 2024
$4.0B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-0.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield SLAB
FY Jan 2026
+1.5%
FY Dec 2024
-0.6%
FY Dec 2023
-1.3%
FY Dec 2022
+1.4%
FY Jan 2022
+0.7%
Jul 2026
-0.1%
Apr 2026
+0.3%
Jan 2026
+1.5%
Oct 2025
+1.7%
Jul 2025
+1.5%
Apr 2025
+3.1%
Dec 2024
-0.6%
Sep 2024
-0.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing SLAB
FY Jan 2026
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Jan 2022
0.00x
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
SLAB ranks highest on growth (75th percentile) and institutional and government (52nd), and lowest on risk and compliance (27th), among Semiconductors & Electronics peers.
Profitability
39
Inputs
Return on equity-3.6% · 39 pct, sector of 154
Return on assets-3.2% · 40 pct, sector of 171
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-3.9% · 37 pct, sector of 155
Financial health
41
Inputs
Debt to equity0.48x · 36 pct, sector of 152
Cash flow to debt0.06x · 47 pct, sector of 136
Growth
75
Inputs
Revenue growth, YoY+34.3% · 75 pct, sector of 194
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
27
Inputs
Net Form 4 buying (codes P and S), 180d-$3.2M · 53 pct, sector of 147
Insider buyers, 180d0 · 0 pct, sector of 151
Institutional and government
52
Inputs
Funds adding, latest quarter166 · 52 pct, sector of 184
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
27
Inputs
Short interest, % of float+7.8% · 41 pct, sector of 221
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+26.6% · 14 pct, sector of 152
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SLAB filings, in plain words
Are Silicon Laboratories insiders buying or selling SLAB?
In the 180 days to 2026-10-28, Silicon Laboratories insiders were net sellers, a net $3.2M across purchases and sales reported on Form 4, by 2 sellers.
Have members of Congress traded SLAB?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Gilbert Cisneros dated 2025-05-06.
Are there planned insider sales of SLAB?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $1.4M of stock; the latest, by CONRAD ROBERT J, was filed 2026-08-14.
Read the full summary
In the 180 days to 2026-10-28, Silicon Laboratories insiders were net sellers of SLAB, a net $3.2M across purchases and sales reported on Form 4 by 2 sellers. Members of Congress have disclosed trades in SLAB, none in the last year; the latest on record is a sale by Gilbert Cisneros dated 2025-05-06. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $1.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.